These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17487771)

  • 21. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.
    Zemljic G; Bunc M; Yazdanbakhsh AP; Vrtovec B
    J Card Fail; 2007 Aug; 13(6):417-21. PubMed ID: 17675054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First experiences with intraoperative Levosimendan in pediatric cardiac surgery.
    Osthaus WA; Boethig D; Winterhalter M; Huber D; Goerler H; Sasse M; Sümpelmann R
    Eur J Pediatr; 2009 Jun; 168(6):735-40. PubMed ID: 18813947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resuscitation from adrenaline resistant electro-mechanical dissociation facilitated by levosimendan in a young man with idiopathic dilated cardiomyopathy.
    Tsagalou EP; Nanas JN
    Resuscitation; 2006 Jan; 68(1):147-9. PubMed ID: 16325323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European experience on the practical use of levosimendan in patients with acute heart failure syndromes.
    Follath F; Franco F; Cardoso JS
    Am J Cardiol; 2005 Sep; 96(6A):80G-5G. PubMed ID: 16181827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levosimendan in cardiac surgery: current best available evidence.
    Raja SG; Rayen BS
    Ann Thorac Surg; 2006 Apr; 81(4):1536-46. PubMed ID: 16564321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful use of levosimendan in a patient during cardiopulmonary bypass.
    Iriz E; Erer D; Unal Y; Zor H; Ozkose Z; Ozdogan ME
    J Card Surg; 2007; 22(2):153-6. PubMed ID: 17338755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The utility of levosimendan in the treatment of heart failure.
    Lehtonen L; Põder P
    Ann Med; 2007; 39(1):2-17. PubMed ID: 17364447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of levosimendan on ventriculo-arterial coupling in patients with ischemic cardiomyopathy.
    Guarracino F; Cariello C; Danella A; Doroni L; Lapolla F; Stefani M; Baldassarri R; Vullo C
    Acta Anaesthesiol Scand; 2007 Oct; 51(9):1217-24. PubMed ID: 17850562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter?
    Yontar OC; Yilmaz MB; Yalta K; Tandoğan I
    Anadolu Kardiyol Derg; 2010 Aug; 10(4):310-6. PubMed ID: 20693125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative treatment with levosimendan in candidates for mechanical circulatory support.
    Sponga S; Ivanitskaia E; Potapov E; Krabatsch T; Hetzer R; Lehmkuhl H
    ASAIO J; 2012; 58(1):6-11. PubMed ID: 22157071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic-pharmacodynamic interrelationships of intravenous and oral levosimendan in patients with severe congestive heart failure.
    Põder P; Eha J; Sundberg S; Antila S; Heinpalu M; Loogna I; Planken U; Rantanen S; Lehtonen L
    Int J Clin Pharmacol Ther; 2003 Aug; 41(8):365-73. PubMed ID: 12940594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levosimendan: a retrospective single-center case series.
    Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA
    J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The vasoactive-inotropic score and levosimendan: time for LVIS?
    Favia I; Vitale V; Ricci Z
    J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):e15-6. PubMed ID: 23507021
    [No Abstract]   [Full Text] [Related]  

  • 36. Levosimendan may improve survival in patients requiring mechanical assist devices for post-cardiotomy heart failure.
    Braun JP; Jasulaitis D; Moshirzadeh M; Doepfmer UR; Kastrup M; von Heymann C; Dohmen PM; Konertz W; Spies C
    Crit Care; 2006 Feb; 10(1):R17. PubMed ID: 16420666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based use of levosimendan in different clinical settings.
    De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M
    Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery.
    Tritapepe L; De Santis V; Vitale D; Guarracino F; Pellegrini F; Pietropaoli P; Singer M
    Br J Anaesth; 2009 Feb; 102(2):198-204. PubMed ID: 19151048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levosimendan for primary graft failure after heart transplantation: a 3-year follow-up.
    Beiras-Fernandez A; Kur F; Kaczmarek I; Frisch P; Weis M; Reichart B; Weis F
    Transplant Proc; 2011; 43(6):2260-2. PubMed ID: 21839251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.